ImmuCell (ICCC) Short Interest Ratio & Short Volume → 🚀 Tap into this explosive trade opportunity asap (From Daily Strike Alliance) (Ad) Free ICCC Stock Alerts $4.39 -0.15 (-3.30%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ImmuCell Short Interest DataCurrent Short Interest3,000 sharesPrevious Short Interest5,100 sharesChange Vs. Previous Month-41.18%Dollar Volume Sold Short$14,640.00Short Interest Ratio0.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares7,812,000 sharesFloat Size5,620,000 sharesShort Percent of Float0.05%Today's Trading Volume29,248 sharesAverage Trading Volume9,841 sharesToday's Volume Vs. Average297% Short Selling ImmuCell ? Sign up to receive the latest short interest report for ImmuCell and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartICCC Short Interest Over TimeICCC Days to Cover Over TimeICCC Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ImmuCell Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20243,000 shares $14,640.00 -41.2%0.1%0.3 $4.88 4/30/20245,100 shares $25,041.00 +13.3%0.1%0.6 $4.91 4/15/20244,500 shares $22,725.00 -26.2%0.1%0.6 $5.05 3/31/20246,100 shares $32,330.00 -4.7%0.1%0.8 $5.30 3/15/20246,400 shares $33,600.00 +1.6%0.1%0.8 $5.25 2/29/20246,300 shares $33,075.00 -20.3%0.1%0.8 $5.25 Get the Latest News and Ratings for ICCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. 2/15/20247,900 shares $39,697.50 +5.3%0.1%0.9 $5.03 1/31/20247,500 shares $39,825.00 -2.6%0.1%0.8 $5.31 1/15/20247,700 shares $39,347.00 -13.5%0.1%0.6 $5.11 12/31/20238,900 shares $45,301.00 +30.9%0.2%0.8 $5.09 12/15/20236,800 shares $31,144.00 +13.3%0.1%0.5 $4.58 11/30/20236,000 shares $27,240.00 -7.7%0.1%0.4 $4.54 11/15/20236,500 shares $32,825.00 -52.2%0.1%0.4 $5.05 10/31/202313,600 shares $68,680.00 +70.0%0.3%0.8 $5.05 10/15/20238,000 shares $40,160.00 -28.6%0.1%0.5 $5.02 9/30/202311,200 shares $59,806.88 +62.3%0.2%0.7 $5.34 9/15/20236,900 shares $36,984.00 +15.0%0.1%0.4 $5.36 8/31/20236,000 shares $27,660.00 No Change0.1%0.4 $4.61 8/15/20236,000 shares $29,700.00 -11.8%0.1%0.5 $4.95 7/31/20236,800 shares $36,924.00 +11.5%0.1%0.6 $5.43 7/15/20236,100 shares $31,049.00 -3.2%0.1%0.6 $5.09 6/30/20236,300 shares $31,500.00 No Change0.1%0.7 $5.00 6/15/20236,300 shares $34,713.00 -6.0%0.1%0.8 $5.51 5/31/20236,700 shares $31,959.00 -30.2%0.1%0.8 $4.77 5/15/20239,600 shares $47,712.00 No Change0.2%1.1 $4.97 10/31/202210,500 shares $84,105.00 -38.2%0.2%1.3 $8.01 10/15/202217,000 shares $133,620.00 +60.4%0.3%2 $7.86 9/30/202210,600 shares $79,288.00 +6.0%0.2%1.2 $7.48 9/15/202210,000 shares $75,700.00 +19.1%0.2%1.1 $7.57 8/31/20228,400 shares $61,236.00 +12.0%0.2%0.9 $7.29 8/15/20227,500 shares $60,450.00 -24.2%0.1%1 $8.06 7/31/20229,900 shares $86,922.00 +32.0%0.2%1.1 $8.78 7/15/20227,500 shares $63,000.00 -13.8%0.1%0.7 $8.40 6/30/20228,700 shares $75,603.00 +24.3%0.2%0.8 $8.69 6/15/20227,000 shares $56,840.00 +1.5%0.1%0.6 $8.12 5/31/20226,900 shares $55,959.00 No Change0.1%0.6 $8.11 5/15/20226,900 shares $55,959.00 -45.2%0.1%0.6 $8.11 4/30/202212,600 shares $122,724.00 +41.6%0.2%1.1 $9.74 4/15/20228,900 shares $79,655.00 -22.6%0.2%0.8 $8.95 3/31/202211,500 shares $110,975.00 +21.1%N/A1.1 $9.65Your $200 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here 3/15/20229,500 shares $82,270.00 +50.8%0.2%0.9 $8.66 2/28/20226,300 shares $51,471.00 -24.1%0.1%0.6 $8.17 2/15/20228,300 shares $68,226.00 +38.3%0.2%0.7 $8.22 1/31/20226,000 shares $48,900.00 -31.0%0.1%0.5 $8.15 1/15/20228,700 shares $76,617.42 +11.5%N/A0 $8.81 12/31/20217,800 shares $62,400.00 +39.3%0.1%1 $8.00 12/15/20215,600 shares $47,824.00 -35.6%0.1%0.8 $8.54 11/30/20218,700 shares $77,691.00 +13.0%0.2%1.5 $8.93 11/15/20217,700 shares $70,840.00 -10.5%0.1%1.2 $9.20 10/29/20218,600 shares $75,680.00 +24.6%0.2%1.1 $8.80 10/15/20216,900 shares $64,032.00 -33.7%0.1%0.9 $9.28 9/30/202110,400 shares $97,344.00 -3.7%0.2%0.8 $9.36 9/15/202110,800 shares $99,252.00 -12.9%0.2%0.8 $9.19 8/31/202112,400 shares $113,584.00 -29.1%0.2%0.9 $9.16 8/13/202117,500 shares $157,675.00 +7.4%0.3%1.4 $9.01 7/30/202116,300 shares $164,141.00 +109.0%0.3%1.1 $10.07 7/15/20217,800 shares $70,200.00 -25.7%0.1%0.5 $9.00 6/30/202110,500 shares $99,750.00 +15.4%0.2%0.8 $9.50 6/15/20219,100 shares $89,553.10 -37.7%0.2%0.7 $9.84 5/28/202114,600 shares $142,642.00 +31.5%0.3%1 $9.77 5/14/202111,100 shares $102,231.00 -11.9%0.2%0.6 $9.21 4/30/202112,600 shares $128,646.00 +46.5%0.2%0.5 $10.21 4/15/20218,600 shares $79,636.00 +28.4%N/A0 $9.26 3/31/20216,700 shares $62,645.00 +19.6%0.1%0.1 $9.35 3/15/20215,600 shares $60,312.00 -5.1%0.1%0.1 $10.77 2/26/20215,900 shares $62,776.00 -10.6%0.1%0.1 $10.64 2/12/20216,600 shares $74,382.00 -14.3%0.1%0.1 $11.27 1/29/20217,700 shares $57,365.00 +63.8%0.2%0.2 $7.45 1/15/20214,700 shares $29,586.50 +14.6%0.1%0.4 $6.30 12/31/20204,100 shares $24,559.00 -28.1%0.1%0.4 $5.99 12/15/20205,700 shares $36,423.00 +67.7%0.1%0.7 $6.39 11/30/20203,400 shares $20,400.00 -5.6%0.1%0.4 $6.00 11/15/20203,600 shares $20,700.00 +50.0%0.1%0.4 $5.75 10/30/20202,400 shares $12,504.00 -74.5%0.1%0.3 $5.21 10/15/20209,400 shares $52,828.00 -42.0%0.2%0.9 $5.62 9/30/202016,200 shares $87,966.00 -3.6%0.3%1.4 $5.43 9/15/202016,800 shares $88,032.00 +162.5%0.3%1 $5.24 8/31/20206,400 shares $33,408.00 -46.2%0.1%0.3 $5.22 8/14/202011,900 shares $66,878.00 -56.7%0.2%0.5 $5.62 7/31/202027,500 shares $136,950.00 +32.9%0.5%0.9 $4.98 7/15/202020,700 shares $125,235.00 +38.9%0.4%0.7 $6.05 6/30/202014,900 shares $71,669.00 +254.8%0.3%0.5 $4.81 6/15/20204,200 shares $17,808.00 +223.1%0.1%0.2 $4.24 5/29/20201,300 shares $5,824.00 -90.3%0.0%0 $4.48 5/15/202013,400 shares $54,404.00 -39.6%0.3%0.4 $4.06 4/30/202022,200 shares $101,498.40 -31.9%0.4%0.8 $4.57 4/15/202032,600 shares $138,550.00 -24.7%0.6%0.7 $4.25 3/31/202043,300 shares $202,644.00 -7.1%0.8%0.5 $4.68 3/13/202046,600 shares $195,254.00 +55.3%0.9%0.9 $4.19 2/28/202030,000 shares $138,000.00 +25.0%0.6%0.4 $4.60Your $200 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here 2/14/202024,000 shares $108,000.00 +410.6%0.5%0.3 $4.50 1/31/20204,700 shares $23,030.00 +4,600.0%0.1%0.1 $4.90 1/15/2020100 shares $501.00 -96.3%N/A0 $5.01 12/31/20192,700 shares $14,634.00 +575.0%0.1%0.3 $5.42 ICCC Short Interest - Frequently Asked Questions What is ImmuCell's current short interest? Short interest is the volume of ImmuCell shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 3,000 shares of ICCC short. 0.05% of ImmuCell's shares are currently sold short. Learn More on ImmuCell's current short interest. What is a good short interest percentage for ImmuCell? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.05% of ImmuCell's floating shares are currently sold short. Is ImmuCell's short interest increasing or decreasing? ImmuCell saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 3,000 shares, a drop of 41.2% from the previous total of 5,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ImmuCell's float size? ImmuCell currently has issued a total of 7,812,000 shares. Some of ImmuCell's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmuCell currently has a public float of 5,620,000 shares. How does ImmuCell's short interest compare to its competitors? 0.05% of ImmuCell's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ImmuCell: Aspira Women's Health Inc. (2.18%), ARCA biopharma, Inc. (30.24%), OncoCyte Co. (3.05%), Cardio Diagnostics Holdings, Inc. (6.97%), Trinity Biotech plc (0.10%), Biomerica, Inc. (2.04%), Alpha Teknova, Inc. (0.34%), Quince Therapeutics, Inc. (6.17%), Reviva Pharmaceuticals Holdings, Inc. (6.38%), Modular Medical, Inc. (0.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short ImmuCell stock? Short selling ICCC is an investing strategy that aims to generate trading profit from ImmuCell as its price is falling. ICCC shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ImmuCell? A short squeeze for ImmuCell occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ICCC, which in turn drives the price of the stock up even further. How often is ImmuCell's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ICCC, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: AWH Short Squeeze ABIO Short Squeeze OCX Short Squeeze CDIO Short Squeeze TRIB Short Squeeze BMRA Short Squeeze TKNO Short Squeeze QNCX Short Squeeze RVPH Short Squeeze MODD Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ICCC) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWall Street Legend Warns: "A Strange Day Is Coming to America"Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.